Beta-blocking drugs increase responsiveness to prostacyclin in hypertensive patients.
D000319:Adrenergic beta-Antagonists / Q000378:metabolism* / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000242:Cyclic AMP / Q000097:blood; D011464:Epoprostenol / Q000502:physiology*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000503:physiopathology*; D008297:Male; D008875:Middle Aged; D011453:Prostaglandins / Q000502:physiology*
D000319:Adrenergic beta-Antagonists; D011453:Prostaglandins; D011464:Epoprostenol; D000242:Cyclic AMP